Cargando…

Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02

Novel treatments for glioblastoma, the most common malignant primary brain tumor, are urgently required. Type I interferons (IFN) are natural cytokines primarily involved in the defense against viral infections, which may also serve a role in the control of cancer, notably in the suppression of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohmann, Birthe, Le Rhun, Emilie, Silginer, Manuela, Epskamp, Mirka, Weller, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068396/ https://www.ncbi.nlm.nih.gov/pubmed/32218815 http://dx.doi.org/10.3892/ol.2020.11362

Ejemplares similares

Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
por: von Achenbach, Caroline, et al.
Publicado: (2020)

Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity
por: Lohmann, Birthe, et al.
Publicado: (2020)

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models()
por: Blomberg, Evelina, et al.
Publicado: (2022)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner
por: Quijano-Rubio, Clara, et al.
Publicado: (2022)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022)

40. AN UPDATE ON THE DEVELOPMENT OF A NEW TOOL TO ASSESS RESPONSE IN LEPTOMENINGEAL METASTASIS
por: Weller, Michael, et al.
Publicado: (2020)

Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition
por: Silginer, Manuela, et al.
Publicado: (2023)

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models
por: Quijano-Rubio, Clara, et al.
Publicado: (2022)

Biological activity of tumor-treating fields in preclinical glioma models
por: Silginer, Manuela, et al.
Publicado: (2017)

Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo
por: Blomberg, Evelina, et al.
Publicado: (2022)

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2020)

Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
por: Seystahl, Katharina, et al.
Publicado: (2022)

A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma
por: Wang, Jia, et al.
Publicado: (2016)

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma
por: Noonan, Janis J., et al.
Publicado: (2019)

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma
por: Hänsch, Lena, et al.
Publicado: (2023)

Co-amplification of Phosphoinositide 3-kinase enhancer A and Cyclin-dependent kinase 4 Triggers Glioblastoma Progression
por: Qi, Qi, et al.
Publicado: (2017)

Centimeter-Level Orbit Determination for TG02 Spacelab Using Onboard GNSS Data
por: Li, Kai, et al.
Publicado: (2018)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
por: Fraedrich, Kirsten, et al.
Publicado: (2005)

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
por: Riess, Christin, et al.
Publicado: (2020)

Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
por: Wolpert, Fabian, et al.
Publicado: (2015)

The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action
por: Chen, Rong, et al.
Publicado: (2021)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6
por: Chen, Shu-Mei, et al.
Publicado: (2013)

Involvement of Phosphatase and Tensin Homolog in Cyclin-Dependent Kinase 4/6 Inhibitor-Induced Blockade of Glioblastoma
por: Liu, Songlin, et al.
Publicado: (2019)

Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
por: Duhamel, Marie, et al.
Publicado: (2022)

Requirement for A-type cyclin-dependent kinase and cyclins for the terminal division in the stomatal lineage of Arabidopsis
por: Yang, Kezhen, et al.
Publicado: (2014)

How we treat patients with leptomeningeal metastases
por: Le Rhun, Emilie, et al.
Publicado: (2019)

Essentials for clinicians: head and neck tumours and neuro-oncology
por: Le Rhun, Emilie
Publicado: (2017)

Integrin inhibition promotes atypical anoikis in glioma cells
por: Silginer, M, et al.
Publicado: (2014)

Smac mimetic-induced upregulation of interferon-β sensitizes glioblastoma to temozolomide-induced cell death
por: Marschall, V, et al.
Publicado: (2015)

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells
por: LIU, WEN-XIN, et al.
Publicado: (2015)

Effects of the Cyclin-Dependent Kinase 10 (CDK10) on the Tamoxifen Sensitivity of Keloid Samples
por: Liu, Ying, et al.
Publicado: (2012)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uee9htbp1rk93t7ql1u8kbv23m